Natasha holds a First Class degree in English from Cambridge University, and an MA in journalism from Goldsmiths College, University of London.

OAV101 IT, a version of the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) that’s administered into the spinal canal, can be safely given to people with spinal muscular atrophy (SMA) who were ...